Skip to search formSkip to main contentSkip to account menu

aminostigmine

Known as: Carbamic acid, dimethyl-, 2-((dimethylamino)methyl)-3-pyridinyl ester, dihydrochloride 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

CarbamatesCholinesterase InhibitorsPyridostigmine Bromide
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In Memory of Robert Georgievich Glushkov
1996
1996
[Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
The properties of aminostigmine in comparison with those of other carbamate inhibitors of cholinesterases have been studied in… 
1996
1996
[The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
The results of application of cholinesterase inhibitors, aminostigmin and galantamin, for treatment of acute poisoning with… 
1995
1995
Correlation between the structure and activity of aminostigmine derivatives containing various substituents at the nitrogen atom of the carbamoyl group
Sixteen aminostigmine derivatives containing various substituents at the nitrogen atom of the carbamoyl group have been prepared… 
1995
1995
[The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
This investigation has been carried out on albino mice. In the first series of experiments, we determined the dependence of LD50… 
1995
1995
[The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
This investigation has been carried out on albino mice. In the first series of experiments, we determined the dependence of LD50… 
1994
1994
Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers
: Experiments on non-inbred albino mice have demonstrated that aminostigmine is an active reversible centrally active… 
1992
1992
[The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
The pharmacological properties of a new drug approved in the USSR for the treatment of cholinolytics poisonings are described… 
1991
1991
[Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
The effect of anesthesia with ketamine (80 mg/kg, intraperitoneally) combined with phenazepam (0.5 mg/kg, subcutaneously) on the… 
1991
1991
Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine
The effect of anesthesia with ketamine (80 mg/kg, intraperitoneally) combined with phenazepam (0.5 mg/kg, subcutaneously) on the…